Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by St. John Providence Health System.
Recruitment status was  Recruiting
Genentech, Inc.
Eli Lilly and Company
Information provided by:
St. John Providence Health System Identifier:
First received: September 6, 2005
Last updated: November 28, 2005
Last verified: September 2005
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given